$ALEC Cashflow Statement | Understand Stock

$ALEC

$2.10 +$0.27 (14.75%) Close

$ALEC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Stock-based compensation
Amortization of premiums and accretion of discounts on marketable securities
Amortization of right-of-use assets
Amortization of debt discount and debt issuance costs
Impairment loss of right-of-use assets and leasehold improvements
Loss from disposal of property and equipment, net
Loss from disposal of fixed assets

Changes in operating assets and liabilities:
Receivable from collaboration partner
Prepaid expenses and other current assets
Other assets
Accounts payable
Accrued liabilities and accrued clinical supply costs
Payable to collaboration partner
Deferred revenue
Refund liability to collaboration partner
Lease liabilities
Other long-term liabilities
Net cash used in operating activities
Cash flows from investing activities:
Purchase of property and equipment
Purchase of marketable securities
Maturities of marketable securities
Sale of marketable securities
Net cash provided by investing activities
Cash flows from financing activities:
Proceeds from issuance of common stock upon public offerings, net of issuance costs
Proceeds from the exercise of options to purchase common stock
Proceeds from issuance of stock from employee stock purchase plan
Proceeds from issuance of common stock, net of issuance costs
Proceeds from issuance of common stock upon public offering, net of issuance costs
Proceeds from debt financing, net of discount and issuance costs
Net cash provided by financing activities

Net increase (decrease) in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash at beginning of period
Cash, cash equivalents, and restricted cash at end of period
Non-cash investing and financing activities:
Property and equipment purchases included in accounts payable and accrued liabilities
Deferred offering costs in accrued liabilities
Tenant improvements paid by landlord
Interest paid

Comments